Invasive pneumococcal disease is a serious infection that primarily affects very young children and elderly or immunocompromised individuals but also affects previously healthy people. Variant mannose-binding lectin (MBL) alleles are associated with recurrent infections and may be a risk factor for pneumococcal infections. To assess the influence of MBL genotypes on the course and outcome of invasive pneumococcal disease, clinical data for 141 adult patients were collected prospectively and their genotypes were determined. All patients included had positive blood cultures for Streptococcus pneumoniae. The distribution of variant MBL alleles related to low MBL serum concentrations was similar among the patients and healthy individuals, and MBL genotype was not associated with infection outcome. Thus, in a random adult population with invasive pneumococcal infection, MBL does not seem to play a role in the pathophysiology, in contrast to earlier observations in patients with other concomitant immune abnormalities.
Mannose-binding lectin (MBL) gene heterogeneity has been associated with susceptibility to infectious diseases in general during childhood, to meningococcal disease, and to severity of lung disease in cystic fibrosis [1] [2] [3] [4] [5] . However, the knowledge of what clinical role MBL may play toward specific pathogens, such as Streptococcus pneumoniae, is limited.
S. pneumoniae is a major cause of community-acquired pneumonia, bacteremia, meningitis, and acute otitis media. The incidence of invasive pneumococcal disease is highest among young children and the elderly, with a range of 14-600 per 100,000 infants and 20-190 per 100,000 adults . 65 years of age [6] . The reason for this variation, except for the geographical difference, is not known. About one-third of adults with invasive pneumococcal disease have no recognized risk factors. The mortality rate, with a range of 10%-40%, is mainly dependent on the age of the patients, with the highest mortality in elderly persons [7] .
MBL is a serum protein participating in the innate immune defense. It is a secreted pattern-recognition molecule, belonging to the calcium-dependent lectin family, and functions as an opsonin. The ligands for MBL, high mannose and N-acetyl-glucosamine oligosaccharides, are present on a variety of microorganisms, including S. pneumoniae. MBL may activate the complement system by MBL-associated serine proteases and may interact with novel receptors on phagocytes [8] . Low MBL serum levels are associated with an increased risk for different types of infections that occur in both children and adults. Moreover, MBL has been shown to play a role in autoimmune diseases [9] .
Human MBL is derived from a single gene on chromosome 10, MBL2. In exon 1 of MBL2, 3 single-base substitutions independently cause low serum levels of MBL, and several nucleotide substitutions in the promoter region of MBL2 also affect the MBL serum level [10] .
We investigated whether the susceptibility to and the outcome or serious complications of invasive pneumococcal disease were related to MBL genotype in consecutively admitted patients in 5 hospitals in Denmark.
Patients and Methods
Patients. Between October 1999 and June 2001, adults (>18 years of age) with S. pneumoniae bacteremia who were admitted to any of 5 university hospitals (Aalborg, Aarhus, Hvidovre, Odense, and Rigshospitalet) in Denmark were included in the study. Clinical data were collected prospectively at the time of admission, and blood samples were drawn for DNA analyses. S. pneumoniae isolates were serotyped, when possible, by group and individual kits of antiserum at the Statens Serum Institute, Copenhagen. Meningitis was diagnosed at the clinical presentation, using the cutoff of cerebrospinal fluid with . 5 leukocytes/mL. Lung infiltrate shown on X-ray film of the thorax was the basis for diagnosing pneumonia. The control group comprised 250 healthy blood donors and laboratory personnel [10] .
MBL genotypes. Genomic DNA was isolated from EDTA blood cells and was stored at 220 C. DNA was amplified by general polymerase chain reaction (PCR) and site-directed mutagenesis PCR, and the MBL alleles were detected as described elsewhere [10] . All 3 structural variant alleles (B, C, and D) have a considerable effect on MBL concentrations, and, to avoid small groups, the 3 alleles were grouped together in 1 category (allele O). The normal allele is designated "A." The 6 MBL genotypes were defined as follows: the A/A group, 2 normal structural alleles with high-expression promoter activity in position 2 221 (YA/YA) or 1 high-expression promoter and 1 low-expression promoter (YA/XA) or 2 low-expression promoters (XA/XA); the A/O group, 1 variant structural allele (i.e., defective allele) and 1 normal structural allele combined with a highexpression promoter (YA/O) or a low-expression promoter (XA/ O); and the O/O group, 2 defective structural alleles.
Statistical analyses. Pearson's x 2 test was used to compare patient data according to the different MBL haplotypes and to compare patients with different clinical characteristics. Logistic regression analysis was performed on clinical data significant for outcome in a univariate analysis. The Mann-Whitney U test was used for comparison of age between the survivors and the nonsurvivors. P , :05 was considered to be significant. All analyses were carried out using SPSS software (version 8.0).
Results
In total, 141 patients (78 women and 63 men) were included (1 man was excluded because of human immunodeficiency virus positivity). DNA was available from 140. The mean age of the patients was 64 years, with a range of 20-99 years. An underlying illness was present in 66% of the patients, with pneumonia being the most common focus of infection (n ¼ 116). Twentytwo patients had meningitis; 24 patients died in the hospital (case fatality rate, 17%). Only 3 patients were not white. The patients' clinical data are given in table 1. Underlying diseases showed only a tendency toward importance for deadly outcome of pneumococcal disease in a univariate statistical analysis, unless the patient was a long-term abuser of alcohol (P ¼ :04). However, when a multivariate logistic regression analysis was performed, underlying chronic disease was an independent risk factor for death due to invasive pneumococcal disease (table 1) . In total, 66 pneumococcal isolates were typed and involved 23 different serotypes, with 4, 6A, 9V, and 14 the most common ones. None of the serotypes were associated with the primary focus or outcome of the infection (data not shown).
All patients received appropriate antibiotic treatment, beginning either at admission or when the blood culture became positive.
The frequency of MBL variant alleles in the patients, as seen in table 2, was identical to the distribution of variant alleles in a healthy Danish population reported earlier [10] . The MBL genotype was not associated with survival of the infection.
In the 22 patients with both meningitis and bacteremia, the results were similar. The frequencies of variant structural MBL alleles and of low-expression promoter alleles were identical to those of the rest of the patients and the healthy control persons. In terms of comorbidity, no difference was seen in MBL haplo- type between previously healthy patients and patients with underlying illness.
Discussion
Invasive pneumococcal disease runs a variable course in different individuals. It has previously been indicated that the variant alleles of the structural gene coding for MBL are associated with susceptibility to meningococcal disease but not with survival of the infection [5] . The results of this study show that, in randomly included patients who have pneumococcal bacteremia, MBL genotypes do not differ from those of healthy control persons. Nor was the MBL genotype associated with the course ofor mortality due to-the infection. This is in contrast to the course of lung infections in selected populations of patients, including patients with cystic fibrosis [3] , with systemic lupus erythematosus (SLE) [9] , and with AIDS [11] . However, in these studies, the causative organisms of pneumonia varied.
It is possible that a putative effect of MBL is revealed only in patients with a concomitant disturbance in the immune system that exposes an MBL phenotype [2] . Another, but not mutually exclusive, possibility is that MBL is not of particular relevance in the defense against S. pneumoniae in the general population. In a recent study by Neth et al. [12] , 5 different isolates of S. pneumoniae were investigated, and none of them showed any binding to MBL in vitro. Previously, in patients with cystic fibrosis, we observed a strong effect of MBL deficiency on the course of chronic infection with Pseudomonas aeruginosa, even though we were not able to detect any binding to the pathogen in vitro [3] . This could have happened because the underlying MBL association was to viral infections known to precede exacerbations of P. aeruginosa infections or because of an immunomodulatory effect of MBL exposed under certain conditions. Nevertheless, a strong predisposing effect of MBL deficiency was observed in the cystic fibrosis patients in their susceptibility to acquire Burkholderia cepacia infection, another major pathogen in patients with cystic fibrosis [3] . B. cepacia has recently been shown to bind MBL [13] .
In diseases with multiple immune abnormalities, such as AIDS and SLE, the MBL status does seem to influence the course of pneumococcal infection [9, 11] . In analogy with the situation in cystic fibrosis and P. aeruginosa infection, this is not necessarily related to specific protection against S. pneumoniae infections per se, but rather to other disease-related phenomenons [9, 11] . Thus, comorbidity, different cofactors, or MBL deficiency may play a significant pathophysiological role in a given situation.
Some of the differences in the course of invasive pneumococcal disease are due to risk factors such as old age, predisposing illness, and delay of treatment [14] . Smoking has been shown to be an independent risk factor for invasive pneumococcal disease [15] , but the influence of smoking on the course of the disease has not been studied and was not considered in our study. Surprisingly, the age of the patient was not significantly related to mortality in our study population. Underlying chronic disease and the severity of disease (as estimated by the need for supportive treatment) at admission had a major impact on the risk of death (table 1) in our group of patients. This is in accordance with a previous study [14] .
In conclusion, in randomly included patients, MBL variant alleles do not seem to be associated with invasive pneumococcal infections, in contrast to what has previously been observed in patients with concomitant immune dysfunctions. 
